15 resources
The aim of Protocol ALL-10 is to improve the overall treatment results in terms of EFS and to decrease treatment intensity in patients with a pEFS of >95%. Therapy will be tailored according to the risk of relapse as determined by the MRD levels at 2...
The Athero-Express Biobank Study (AE) and the Abdominal Aortic Aneurysm-Express Biobank Study (AAA) are two ongoing, prospective biobank studies initiated in 2002 and 2003, respectively. Together, they comprise detailed histological and clinical data...
The BioDay registry is a disease or condition registry for atopic dermatitis (AD)/prurigo nodularis (PN). All patients treated with advanced systemic therapy (biologics and JAK inhibitors [JAKi]) for AD are eligible for inclusion in the prospective, ...
EPIC is the European Prospective Investigation Into Cancer and Nutrition. EPIC-NL is the Dutch contribution to EPIC and comprises about 40,000 individuals prospectively followed since the early 90's. Biological samples have been stored in liquid nitr...
Welkom bij Health Data Space Utrecht, het portaal dat de regio Utrecht verbindt door onderzoekers en professionals samen te brengen om kennis en data te delen....
MARS is a multicenter prospective cohort of ICU patients aimed at developing new molecular technologies for early diagnosis and risk stratification of sepsis. MARS contains comprehensive clinical data (including admission diagnoses, comorbidities, da...
MOMENTUM aims to accelerate the technical and clinical development of Anatomic and Biologic MRGRT and facilitate the evidence-based introduction of the MR-Linac into clinical practice. In MOMENTUM, from all adult patients treated on the MR-Linac, tec...
Baseline standard clinical pre-perinatal and post-natal characteristics, maternal and neonatal risk factors, morbidities and the most common complications during the neonatal period, longitudinal follow up,...
Cohort of patients with advanced cutaneous melanoma treated with first-line immune checkpoint inhibition from 11 treatment centers in the Netherlands. Collected data: Clinical data (age, sex, treatment type, BRAF mutation status, WHO performance st...
The PRESENT+ cohort is a Dutch prospective multicenter cohort including patients with bone metastases referred to the departments of radiation oncology or orthopedic surgery. The cohort started in 2013 and is still ongoing. PRESENT+ follows the Tria...
